AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34279606 — intervention group
Group type: COMPARATOR
Intervention: Control group (blinded coronary physiology assessment)
Number of subjects: 260
Study 32032923 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (2‐4 mg q 24 h) and benazepril (0.25‐0.5 mg q 24 h)
Number of subjects: 184
Study 32032923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 184
Study 32032923 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone and benazepril
Number of subjects: 184
Study 36057612 — intervention group
Group type: EXPERIMENTAL
Intervention: HEALTHY‐MIND©
Number of subjects: 60
Study 36057612 — intervention group
Group type: EXPERIMENTAL
Intervention: DEEPSEN©
Number of subjects: 60
Study 36401916 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive virtual reality sessions (three sessions)
Number of subjects: 19
Study 36401916 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 19
Study 33784428 — intervention group
Group type: EXPERIMENTAL
Intervention: Height increase (1 SD)
Number of subjects: 0
Study 33784428 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 0
Study 33784428 — intervention group
Group type: COMPARATOR
Intervention: WHR, HC, WC (adjusted for BMI)
Number of subjects: 0
Study 35939350 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 6 ml/kg
Number of subjects: 2860
Study 35939350 — intervention group
Group type: COMPARATOR
Intervention: Tidal volume of 10 ml/kg
Number of subjects: 2860
Study 35939350 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP of 5 cm H2O
Number of subjects: 2860
Study 35939350 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 8 cm H2O
Number of subjects: 2860
Study 33687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual resiliency training
Number of subjects: 0
Study 33687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Number of subjects: 0
Study 33687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported education and employment
Number of subjects: 0
Study 33687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural assessment for medication
Number of subjects: 0
Study 35280426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent dose apatinib (500 mg/d for 5 days, then 2 days off) plus docetaxel (60 mg/m2 q3w)
Number of subjects: 76
Study 35280426 — intervention group
Group type: COMPARATOR
Intervention: Continuous dose apatinib (500 mg daily) plus docetaxel (60 mg/m2 q3w)
Number of subjects: 76
Study 32409106 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab
Number of subjects: 1798
Study 32409106 — intervention group
Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 1798
Study 35639493 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER intervention (digital smartphone app for monitoring well-being)
Number of subjects: 86
Study 35639493 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 86
Study 35639493 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER intervention
Number of subjects: 86
Study 33200390 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% tropicamide
Number of subjects: 83
Study 33200390 — intervention group
Group type: COMPARATOR
Intervention: 1% cyclopentolate hydrochloride
Number of subjects: 83
Study 32741788 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electric stimulation
Number of subjects: 60
Study 32741788 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional physical therapy only)
Number of subjects: 60
Study 35570898 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week tailored web-based educational lifestyle program
Number of subjects: 35
Study 35570898 — intervention group
Group type: COMPARATOR
Intervention: 6-week generic standard-care educational course
Number of subjects: 35
Study 33940670 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice A
Number of subjects: 161
Study 33940670 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice B
Number of subjects: 161
Study 33940670 — intervention group
Group type: COMPARATOR
Intervention: Zn/Arg dentifrice
Number of subjects: 161
Study 33940670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SnF2 dentifrices
Number of subjects: 161
Study 33940670 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 161
Study 34274622 — intervention group
Group type: EXPERIMENTAL
Intervention: Arts therapies (including story-making, story-telling, drawings, puppetry, songwriting, and empowerment activities)
Number of subjects: 62
Study 32991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported living with HIV and on ART
Number of subjects: 5662
Study 32991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported living with HIV and not on treatment
Number of subjects: 5662
Study 32991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-identifying PLHIV with internalized stigma
Number of subjects: 5662
Study 32991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-identifying PLHIV without internalized stigma
Number of subjects: 5662
Study 32691984 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0
Study 32691984 — intervention group
Group type: COMPARATOR
Intervention: Galantamine
Number of subjects: 0
Study 32691984 — intervention group
Group type: COMPARATOR
Intervention: Rivastigmine
Number of subjects: 0
Study 35522990 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively engaging physical activity (CPA; storytelling, cognitive activities, and motor tasks, n = 55)
Number of subjects: 144
Study 35522990 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition (storytelling and cognitive activities without motor tasks, n = 48)
Number of subjects: 144
Study 35522990 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional storytelling, n = 41)
Number of subjects: 144
Study 34965588 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal height
Number of subjects: 556
Study 34965588 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal height
Number of subjects: 556
Study 34965588 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal glucose, insulin resistance, and fetal C-peptide
Number of subjects: 556
Study 35435818 — intervention group
Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 254
Study 35435818 — intervention group
Group type: COMPARATOR
Intervention: Uterine artery embolisation
Number of subjects: 254
Study 33596937 — intervention group
Group type: EXPERIMENTAL
Intervention: PPIUD intervention
Number of subjects: 96
Study 36239883 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine‐tipiracil plus bevacizumab
Number of subjects: 31
Study 36239883 — intervention group
Group type: COMPARATOR
Intervention: Trifluridine‐tipiracil monotherapy
Number of subjects: 31
Study 32051344 — intervention group
Group type: EXPERIMENTAL
Intervention: Kisspeptin
Number of subjects: 0
Study 35681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health nurses
Number of subjects: 8975
Study 35681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 8975
Study 35681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health nurses (after adjustment)
Number of subjects: 8975
Study 35681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses (after adjustment)
Number of subjects: 8975
Study 33245847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous belimumab 10 mg/kg every 4 weeks
Number of subjects: 53
Study 33245847 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 53
Study 36273149 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (RYGB)
Number of subjects: 220
Study 36273149 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic one-anastomosis gastric bypass (OAGB)
Number of subjects: 220
Study 36273149 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 220
Study 36273149 — intervention group
Group type: COMPARATOR
Intervention: OAGB
Number of subjects: 220
Study 33572416 — intervention group
Group type: EXPERIMENTAL
Intervention: Matured Peruíbe Black Mud (PBM)
Number of subjects: 41
Study 33572416 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterilized Peruíbe Black Mud (PBM)
Number of subjects: 41
Study 33572416 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 41
Study 35669048 — intervention group
Group type: EXPERIMENTAL
Intervention: Beyond Burger (PBMA)
Number of subjects: 30
Study 35669048 — intervention group
Group type: COMPARATOR
Intervention: Lamb
Number of subjects: 30
Study 35669048 — intervention group
Group type: COMPARATOR
Intervention: Pasture
Number of subjects: 30
Study 35669048 — intervention group
Group type: COMPARATOR
Intervention: Grain
Number of subjects: 30
Study 34975168 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal remedy for treatment of canine osteoarthritis pain
Number of subjects: 24
Study 34975168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33332813 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 1011
Study 33332813 — intervention group
Group type: COMPARATOR
Intervention: Systemic medications (including cholinesterase inhibitor, ACE inhibitors, calcium channel blockers, beta‐blockers, diuretics, aspirin, steroids, statins, hormone replacement therapy, antacids, and drugs targeting G protein‐coupled receptors)
Number of subjects: 1011
Study 35543459 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand expressing and breast massage within the 1st hr of birth
Number of subjects: 31
Study 35543459 — intervention group
Group type: COMPARATOR
Intervention: Standard care, hand expressing within 6 hr of birth
Number of subjects: 31
Study 34186487 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vaginal microbes (CS-seeded)
Number of subjects: 25
Study 34186487 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (CS-placebo)
Number of subjects: 25
Study 34186487 — intervention group
Group type: COMPARATOR
Intervention: Vaginally-born neonates (VB)
Number of subjects: 25
Study 35912303 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception picture‐based nutrition education and counselling along with iron-folic acid supplementation (IFAS)
Number of subjects: 244
Study 35912303 — intervention group
Group type: COMPARATOR
Intervention: Preconception iron-folic acid supplementation (IFAS) only
Number of subjects: 244
Study 32688368 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements (various types) for 12 weeks
Number of subjects: 279
Study 32861377 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 162
Study 32861377 — intervention group
Group type: COMPARATOR
Intervention: Sham preconditioning
Number of subjects: 162
Study 36272309 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilepsy self-management (ESM) intervention
Number of subjects: 627
Study 36272309 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 627
Study 33001400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical model for predicting intracranial pressure (ICP) based on phase‐contrast cine MRI (PC‐MRI) parameters.
Number of subjects: 138
Study 33001400 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 138
Study 36305992 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusional 5-FU for 7 days starting within 24 hours after curative resection (arm A)
Number of subjects: 855
Study 36305992 — intervention group
Group type: COMPARATOR
Intervention: No perioperative 5-FU (arm B)
Number of subjects: 855
Study 36305992 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusional 5-FU for 7 days (arm A)
Number of subjects: 855
Study 32319465 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice enriched with highly polymerized inulin (12 g per 300 mL)
Number of subjects: 20
Study 32319465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35391574 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity (HI) exercise
Number of subjects: 577
Study 35391574 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-Moderate Intensity (LMI) exercise
Number of subjects: 577
Study 35391574 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 577
Study 34235773 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-COVID-19 condition (retrospective assessment)
Number of subjects: 6578
Study 34235773 — intervention group
Group type: COMPARATOR
Intervention: Current condition (during the pandemic assessment)
Number of subjects: 6578
Study 34235773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyber bullying
Number of subjects: 6578
Study 34235773 — intervention group
Group type: COMPARATOR
Intervention: East Asian Canadian students vs. White students
Number of subjects: 6578
Study 34235773 — intervention group
Group type: COMPARATOR
Intervention: Gender comparison
Number of subjects: 6578
Study 34235773 — intervention group
Group type: COMPARATOR
Intervention: Elementary vs. Secondary students
Number of subjects: 6578
Study 34235773 — intervention group
Group type: COMPARATOR
Intervention: Gender diverse and LGBTQ+ students
Number of subjects: 6578
Study 33234155 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized LTC‐ED care and referral pathway with targeted INTERACT® tools
Number of subjects: 38
Study 33234155 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-implementation qualitative assessment of the pathway
Number of subjects: 38
Study 33234155 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative cost-analysis from the perspective of publicly funded health care
Number of subjects: 38
Study 35320494 — intervention group
Group type: EXPERIMENTAL
Intervention: RECOVEREEZ FORTE™ (500 mg thrice daily for 10 days)
Number of subjects: 64
Study 35320494 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard of care and oral Prednisolone in tapered dosage)
Number of subjects: 64
Study 35320494 — intervention group
Group type: EXPERIMENTAL
Intervention: RECOVEREEZ FORTE™
Number of subjects: 64
Study 35320494 — intervention group
Group type: EXPERIMENTAL
Intervention: IFM RT-PCR test
Number of subjects: 64
Study 34132351 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (GLN)
Number of subjects: 16
Study 34132351 — intervention group
Group type: COMPARATOR
Intervention: Negative control (GRY)
Number of subjects: 16
Study 34132351 — intervention group
Group type: COMPARATOR
Intervention: Positive control (GNY)
Number of subjects: 16
Study 32780739 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise with mask (CE‐ARM)
Number of subjects: 18
Study 32780739 — intervention group
Group type: COMPARATOR
Intervention: Continuous exercise without mask (CE)
Number of subjects: 18
Study 35245946 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive membrane sweeping with Foley catheter
Number of subjects: 63
Study 35245946 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter (no membrane sweeping)
Number of subjects: 63
Study 33707267 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleuran oral suspension
Number of subjects: 120
Study 33707267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33347725 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive complementary feeding and play group (RCF&P group)
Number of subjects: 600
Study 33347725 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary feeding group (CF group)
Number of subjects: 600
Study 33347725 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 600
Study 35574029 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-Restricted Feeding (TRF)
Number of subjects: 12
Study 33635238 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine-Tryptophan-Ketoglutarate (HTK) solution
Number of subjects: 320
Study 33635238 — intervention group
Group type: COMPARATOR
Intervention: Blood cardioplegia
Number of subjects: 320
Study 35327782 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA apical plugs
Number of subjects: 24
Study 35327782 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine apical plugs
Number of subjects: 24
Study 35327782 — intervention group
Group type: COMPARATOR
Intervention: Control (MTA)
Number of subjects: 24
Study 35327782 — intervention group
Group type: COMPARATOR
Intervention: Control (Biodentine)
Number of subjects: 24
Study 32591004 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) - loading dose of 1 μg/kg over 10 min followed by continuous infusion of 0.5 μg/kg/h until the end of surgery
Number of subjects: 200
Study 32591004 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline) - equal volume loading dose followed by equal volume continuous infusion until the end of surgery
Number of subjects: 200
Study 35363122 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min Stroop task
Number of subjects: 0
Study 35363122 — intervention group
Group type: COMPARATOR
Intervention: 30‐min documentary program
Number of subjects: 0
Study 35363122 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective ratings of mental fatigue
Number of subjects: 0
Study 35363122 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analog scale
Number of subjects: 0
Study 32521538 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic SCFA delivery (10 g and 20 g of arabinoxylan oligosaccharides)
Number of subjects: 66
Study 32521538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 36379436 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong Together serious game
Number of subjects: 336
Study 36379436 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual
Number of subjects: 336
Study 32595137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (10 hours/week for 6 months) including medication reviews, prescribing advice, clinical audits, and education.
Number of subjects: 786
Study 32595137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention for older adults (aged ≥65 years) with polypharmacy.
Number of subjects: 786
Study 34825613 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 96
Study 34825613 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 96
Study 32062048 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of once-weekly rifapentine plus isoniazid (group A)
Number of subjects: 2618
Study 32062048 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of twice-weekly rifapentine plus isoniazid (group B)
Number of subjects: 2618
Study 32062048 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls (group C)
Number of subjects: 2618
Study 32062048 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated participants with higher baseline IFN-γ levels
Number of subjects: 2618
Study 32062048 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls with higher baseline IFN-γ levels
Number of subjects: 2618
Study 34455455 — intervention group
Group type: EXPERIMENTAL
Intervention: New screwed Amplatz sheath (Group B)
Number of subjects: 100
Study 34455455 — intervention group
Group type: COMPARATOR
Intervention: Conventional Amplatz sheath (Group A)
Number of subjects: 100
Study 34971614 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring (CVR) releasing NES and E2
Number of subjects: 443
Study 34971614 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-range NES concentrations
Number of subjects: 443
Study 32127255 — intervention group
Group type: EXPERIMENTAL
Intervention: Active‐Start intervention (daily before-school physical activity program for 8 weeks)
Number of subjects: 170
Study 32127255 — intervention group
Group type: EXPERIMENTAL
Intervention: Active‐Start intervention
Number of subjects: 170
Study 35083341 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Ligilactobacillus salivarius LS01 1 × 10^9 live cells and Bifidobacterium breve B632 1 × 10^9 live cells) taken twice daily for eight weeks and then once daily for another eight weeks
Number of subjects: 422
Study 35083341 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Ligilactobacillus salivarius LS01 and Bifidobacterium breve)
Number of subjects: 422
Study 35083341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 33743670 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented exercises
Number of subjects: 70
Study 32033579 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of antipsychotic medication until at least 1 year after remission (original dose allowing a maximum reduction of 25%, or another antipsychotic drug in similar dose range)
Number of subjects: 512
Study 32033579 — intervention group
Group type: COMPARATOR
Intervention: Gradual dose reduction till eventual discontinuation of antipsychotics according to a tapering schedule
Number of subjects: 512
Study 32030432 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care + nature-based rehabilitation
Number of subjects: 101
Study 32030432 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 101
Study 34751427 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation at 90°C for 50 seconds
Number of subjects: 96
Study 34751427 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation at 85°C for 60 seconds
Number of subjects: 96
Study 34751427 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation at 70°C for 90 seconds
Number of subjects: 96
Study 34751427 — intervention group
Group type: COMPARATOR
Intervention: All groups (90°C, 85°C, 70°C)
Number of subjects: 96
Study 34484368 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with midazolam with/out pethidine
Number of subjects: 275
Study 34484368 — intervention group
Group type: COMPARATOR
Intervention: Uns sedation
Number of subjects: 275
Study 34484368 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain during rectal examination
Number of subjects: 275
Study 35759555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 250
Study 35759555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 250
Study 35759555 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 250